RegenMD - STEM 2011, the 7th Annual Conference on Biotechnology - to Be Held ...

RegenMD         STEM 2011, the 7th Annual Conference on Biotechnology - to Be Held ... January 5, 2011 at 9:54 PM   Focusing on latest trends in Stem Cells, Regenerative Medicine and Tissue Engineering. Stem Cell research a very frontline subject all over the world. ...         Milestone: 3000th Dog Treated With Vet-Stem Cell Therapy January 5, 2011 at 5:15 PM   Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. In January of 2004, Vet-Stem introduced the first veterinary ... See all stories on this topic »         BioMimetic Therapeutics, Inc. to Present at the J.P. Morgan Healthcare Conference January 5, 2011 at 3:04 PM   Through the commercialization of this patented technology, BioMimetic seeks to become the leading company in the field of regenerative medicine by providing ... See all stories on this topic »         Juventas wins approval for a Phase 2 trial on critical limb ischemia treatment January 5, 2011 at 1:06 PM   Regenerative medicine company Juventas Therapeutics Inc. wins Food & Drug Administration approval to begin a Phase 2 clinical trial on critical limb ... See all stories on this topic »         Juventas Therapeutics Initiating Phase II Clinical Trial Of JVS-100 For ... January 5, 2011 at 1:06 PM   Juventas Therapeutics, a clinical-stage regenerative medicine company developing novel therapies for cardiovascular disease, announces that the US Food and ... See all stories on this topic »         Faster, Scalable Method for Producing AAV-Based Gene Transfer Vectors January 5, 2011 at 10:28 AM   ... in many promising areas of science and biomedical research, including Tissue Engineering, Stem Cells and Development, and Cellular Reprogramming. ... PRLog.Org         Advanced BioHealing to Present at 29th Annual J.P. Morgan Healthcare Conference January 5, 2011 at 9:20 AM   Also during the JP Morgan conference, Dean Tozer, Senior Vice President of ABH will participate in the "Regenerative Medicine State of the Industry ... See all stories on this topic »         UTHealth Studies Cord Blood Stem Cells for Pediatric Traumatic Brain Injury January 5, 2011 at 9:20 AM   "Implementing this novel therapy has required strong partnerships with Children's Memorial Hermann Hospital and the CBR Center for Regenerative Medicine, ... See all stories on this topic »         Research and Markets: Cell Therapy - an Updated Technologies ... January 5, 2011 at 9:12 AM   Cell therapy technologies overlap with those of gene therapy, cancer vaccines, drug delivery, tissue engineering and regenerative medicine. ...         Graftys Completes Third Round of Financing for 4 Million Euros ($5 ... January 5, 2011 at 8:58 AM   Company technologies provide innovative therapeutic products through bone tissue engineering. Graftys is at the leading edge of combination products (ie ...         NOTCH1 and NOTCH3 coordinate esophageal squamous differentiation through a CSL-dependent transcriptional network. January 5, 2011 at 7:53 AM   NOTCH1 and NOTCH3 coordinate esophageal squamous differentiation through a CSL-dependent transcriptional network. Gastroenterology. 2010 Dec;139(6):2113-23 Authors: Ohashi S, Natsuizaka M, Yashiro-Ohtani Y, Kalman RA, Nakagawa M, Wu L, Klein-Szanto AJ, Herlyn M, Diehl JA, Katz JP, Pear WS, Seykora JT, Nakagawa H The Notch receptor family regulates cell fate through cell-cell communication. CSL (CBF-1/RBP-jκ, Su(H), Lag-1) drives canonical Notch-mediated gene transcription during cell lineage specification, differentiation, and proliferation in the hematopoietic system, the intestine, the pancreas, and the skin. However, the functional roles of Notch in esophageal squamous epithelial biology are unknown. PMID: 20801121 [PubMed - indexed for MEDLINE]             This email was sent to agupta1213+termsc@gmail.com. Delivered by Feed My Inbox PO Box 682532 Franklin, TN 37068 Account Login Unsubscribe Here